- Home
- CMPX vs EPM Comparison
CMPX vs EPM Comparison
Compare CMPX & EPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CMPX | EPM |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 752.4M | 136.3M |
| IPO Year | N/A | 1996 |
Fundamental Metrics
Financial Performance| Metric | CMPX | EPM |
|---|---|---|
| Price | $5.14 | $3.55 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 10 | 2 |
| Target Price | ★ $13.44 | $4.75 |
| AVG Volume (30 Days) | ★ 2.2M | 427.7K |
| Earning Date | 11-05-2025 | 02-10-2026 |
| Dividend Yield | N/A | ★ 13.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $85,232,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.33 | $3.51 |
| 52 Week High | $5.86 | $5.70 |
Technical Indicators
Market Signals| Indicator | CMPX | EPM |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 27.97 |
| Support Level | $4.83 | $4.02 |
| Resistance Level | $5.32 | $3.85 |
| Average True Range (ATR) | 0.30 | 0.12 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 33.51 | 5.30 |
Price Performance
Historical ComparisonAbout CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About EPM Evolution Petroleum Corporation Inc.
Evolution Petroleum Corp is an independent energy company focused on owning and investing in onshore oil and natural gas properties across the United States. Its portfolio includes non-operated interests in various production fields such as CO2 enhanced oil recovery in Louisiana, secondary recovery production in Wyoming, and shale gas reservoirs in Texas and North Dakota. The company generates revenue from the production and sale of oil and natural gas, leveraging specialized technologies to extend reservoir life and enhance recoveries.